The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s inhalation anesthesia market report forecasts the inhalation anesthesia market size to grow to $1.9 Billion by 2027, with a CAGR (compound annual growth rate) of more than 7%.

Learn More On The Inhalation Anesthesia Market Report 2023 – https://www.thebusinessresearchcompany.com/report/inhalation-anesthesia-global-market-report

Inhalation Anesthesia Market Size Forecast
The global inhalation anesthesia market is expected to grow from $1.36 billion in 2022 to $1.45 billion in 2023 at a compound annual growth rate (CAGR) of 6.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The inhalation anesthesia market size is expected to grow to $1.9 billion in 2027 at a CAGR of 7.1%.

North America held the largest inhalation anesthesia market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Inhalation Anesthesia Market Driver ­– Increase In The Geriatric Population
For instance, in 2020, according to a United Nations report, the share of the population aged 65 years or over is expected to increase from 9.3% in 2020 to around 16.0% in 2050. Therefore, the increasing geriatric population is expected to boost demand for inhalation anesthesia during the forecast period.

Request for A Sample Of The Global Inhalation Anesthesia Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7198&type=smp

Key Inhalation Anesthesia Market Trend – Technological Advancement
Many companies operating in inhalation anesthesia are developing new products or new technologies to meet industry demands and strengthen the market position across the globe. For instance, in April 2020, Hikma Pharmaceuticals plc, a UK-based manufacturer of non-branded generic and in-licensed pharmaceutical products launched Vecuronium Bromide for Injection, 10mg. Vecuronium Bromide for Injection is used as an adjunct to general anesthesia to help with endotracheal intubation and to relax skeletal muscles during surgery or mechanical ventilation.

Inhalation Anesthesia Market Segment
1) By Product: Sevoflurane, Desflurane, Isoflurane, Nitrous Oxide
2) By Application: Induction, Maintenance
3) By End User: Hospitals, Ambulatory Surgical Centers

Inhalation Anesthesia Market Major Players and Strategies
Major players in the inhalation anesthesia market are Abbvie Inc., Baxter International Inc., Fresenius SE & Co. KGaA, Halocarbon Products Corporation, Hikma Pharmaceuticals PLC, Lunan Pharmaceutical Group Co. Ltd., Piramal Enterprises Ltd., Troikaa Pharmaceuticals, Ltd., Jiangsu Hengrui Medicine Co., Ltd., and Sandoz International GmbH.

In January 2022, Dechra Pharmaceuticals UK-based specialist veterinary pharmaceuticals and related products business acquired Isoflurane USP Inhalant Anesthetic and Sevoflurane USP Inhalant Anesthetic from Halocarbon Life Sciences for an undisclosed amount. With this acquisition, Isoflurane and Sevoflurane come as an addition to Dechra’s pharmaceutical companion animal portfolio Dechra’s companion animal portfolio, focusing on endocrinology, anesthesia, fluid therapy, dermatology, ophthalmology, pain management, joint health support, and dental care. Halocarbon Life Sciences is a US-based leader in the supply of isoflurane and sevoflurane inhalation anesthetic products for human and veterinary applications.

The Inhalation Anesthesia Global Market Report 2023 covers regional data on inhalation anesthesia market size, inhalation anesthesia market trends and drivers, opportunities, strategies, and inhalation anesthesia market competitor analysis. The countries covered in the inhalation anesthesia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Inhalation anesthesia refers to medications used in operating rooms to induce and maintain general anaesthesia. In addition to other therapeutic effects, it causes drowsiness that ranges from mild to severe, up to and including general anaesthesia. The inhalation anesthesia is used for the induction and maintenance of general anesthesia in the operating room.

View More Reports Related To The Inhalation Anesthesia Market –
Anesthesia Disposables Global Market Report 2023
Anesthetics Global Market Report 2023
Inhalation Sedatives Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: